# contextual query Pro-inflammatory TAMs

Query: The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Myeloid.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['APBB1IP', 'DOCK8', 'ST6GAL1', 'CD74', 'SLC1A3', 'LRMDA', 'OLR1', 'SPP1', 'LPCAT2', 'SRGN']

The gene list you provided—**APBB1IP, DOCK8, ST6GAL1, CD74, SLC1A3, LRMDA, OLR1, SPP1, LPCAT2, SRGN**—encompasses a variety of functions that, examined together, provide insight into the **state, properties, and interactions of myeloid cells** in the glioblastoma tumor microenvironment. Below, I analyze their collective implications across tumor biology, normal immunology, cell-cell interactions, and metabolic states.

---

### 1. Cell Migration, Adhesion, and Trafficking

- **APBB1IP (RIAM):** Acts as an adaptor for integrin activation and is key for leukocyte adhesion and migration, including T cell–DC interactions and myeloid cell trafficking.
- **DOCK8:** Functions as a guanine nucleotide exchange factor (GEF) for actin cytoskeleton remodeling. It's essential for immune synapse formation, antigen presentation, and efficient migration of dendritic and myeloid cells.

**Implication:** Their co-enrichment suggests these myeloid cells possess a highly migratory and interactive phenotype, likely supporting dynamic movement within the tumor and potentially facilitating interactions with both tumor and immune cells.

---

### 2. Immunomodulation and Antigen Presentation

- **CD74:** Beyond being the MHC II invariant chain (chaperoning peptide loading), CD74 also serves as a receptor for macrophage migration inhibitory factor (MIF), influencing inflammation and survival signals in myeloid cells.
- **OLR1 (LOX-1):** Scavenger receptor that binds oxidized lipids and is upregulated in tumor-associated myeloid cells; involved in endocytosis, foam cell formation, and can drive immune-suppressive (M2-like) polarization.
- **SPP1 (Osteopontin):** Multifunctional cytokine involved in myeloid recruitment, immune suppression, and tissue remodeling. High SPP1 is linked to pro-tumor, suppressive macrophage phenotypes.

**Implication:** These genes highlight a myeloid subpopulation with strong potential for antigen handling but also *active immune modulation*, especially skewing toward immune suppression and tissue support typical of tumor-associated macrophages (TAMs) or myeloid-derived suppressor cells (MDSCs)[4]. High SPP1/OLR1 expression is commonly seen in *M2-like* macrophages in tumors and wound healing and is associated with T cell exclusion and immune evasion.

---

### 3. Metabolic Reprogramming

- **LPCAT2:** Involved in phospholipid metabolism and pro-inflammatory mediator generation (e.g., platelet-activating factor). Its upregulation can support membrane remodeling necessary for phagocytosis, vesicle trafficking, and inflammatory responses.
- **ST6GAL1:** Adds sialic acid residues to glycoproteins, modulating cell surface glycosylation, which affects cell-cell interactions and immune evasion. Upregulated ST6GAL1 is a feature of both activated and suppressive immune states.
- **SLC1A3 (EAAT1):** Glutamate transporter involved in amino acid metabolism and regulation of extracellular glutamate. In myeloid cells, can contribute to metabolic adaptation within nutrient-poor, hypoxic tumor regions[4].

**Implication:** These genes suggest a myeloid metabolic state adapted for the hypoxic, nutrient-altered conditions of the tumor microenvironment, likely supporting cell survival, migration, and functional plasticity[4]. The adaptation includes altered amino acid and lipid metabolism, consistent with what's seen in TAMs/MDSCs under metabolic stress.

---

### 4. Secretory and Regulatory Dynamics

- **SRGN (Serglycin):** A proteoglycan crucial for the storage and secretion of cytokines, chemokines, and proteases. In myeloid cells, enables release of immune mediators and matrix-degrading enzymes—functions important for both immune regulation and tissue remodeling.
- **SPP1:** Also plays a direct role in ECM remodeling and cell recruitment via secretion into the microenvironment.

**Implication:** These genes support a phenotype of *active secretion*—either of immune-regulatory factors or matrix modulators—that alter the tumor milieu, attract additional immune cells, and/or promote tumor invasion.

---

### 5. Developmental and Differentiation Aspects

- **LRMDA:** Associated with the regulation of melanocyte differentiation, but its expression in myeloid cells is less characterized; may reflect broader plasticity or developmental state.

---

### 6. Integration: Tumor and Homeostatic Functions

**In tumors:** The combined expression of these genes in glioblastoma myeloid cells points to a population with **high plasticity, migratory and antigen-handling capacity, and profound immunosuppressive and tissue-remodeling functions**. Metabolic adaptations (lipid/amino acid changes) and active secretory machinery equip these cells to thrive in, shape, and defend the tumor microenvironment from effective antitumor immunity[4].

**In normal tissue:** Many of these genes are associated with *homeostatic functions*—antigen presentation (CD74), tissue patrol and repair (SPP1, OLR1), metabolic adaptation to injury (SLC1A3, LPCAT2), and immune cell migration (APBB1IP, DOCK8). Their collective upregulation in noncancer settings often marks *activated*, *repair-oriented*, or *developmental* myeloid states (e.g., wound healing, inflammation, neuroinflammation).

---

**Summary Table: Gene Functions and Implications**

| Gene      | Property in Myeloid Cells      | Relevance in TME/Myeloid State       |
|-----------|-------------------------------|--------------------------------------|
| APBB1IP   | Integrin activation/migration | Motility, trafficking                |
| DOCK8     | Cytoskeletal remodeling       | Antigen presentation, migration      |
| ST6GAL1   | Sialylation                  | Immune modulation, evasion           |
| CD74      | Antigen processing, MIF signal| Antigen presentation, inflammation   |
| SLC1A3    | Glutamate transport           | Metabolic adaptation                 |
| LRMDA     | Differentiation signaling     | Plasticity, possible dedifferentiation|
| OLR1      | Lipid uptake, scavenging      | Foam cell, M2 polarization           |
| SPP1      | Cytokine, ECM remodeling      | Suppression, angiogenesis, migration |
| LPCAT2    | Phospholipid remodeling       | Metabolic adaptation, inflammation   |
| SRGN      | Secretory function            | Cytokine/chemokine packaging         |

---

**Conclusion:**  
This gene signature defines a population of **glioblastoma-associated myeloid cells** that are highly interactive, metabolically reprogrammed, and competent for both immune regulation and tissue remodeling. These features underpin both their homeostatic/adaptive roles (e.g., migration, antigen presentation, repair) and their pathological functions in the tumor (immunosuppression, support of tumor progression, metabolic adaptation to stress)[4]. Their collective biology makes them central players in both local immunity and tumor support, suggesting possible targets for therapeutic reprogramming.



## References

- [1] Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment https://aacrjournals.org/cancerimmunolres/article/7/7/1079/469513/Hypoxia-Induced-VISTA-Promotes-the-Suppressive 2019-05-14 None
- [2] MicroRNA networks regulate the differentiation, expansion and suppression function of myeloid-derived suppressor cells in tumor microenvironment http://www.jcancer.org/v10p4350.htm 2019-07-10 None
- [3] Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells http://www.tandfonline.com/doi/full/10.1080/2162402X.2015.1063772 2016-01-02 None
- [4] Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment https://www.mdpi.com/1422-0067/25/22/12223 2024-11-01 None
- [5] Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment https://www.mdpi.com/2072-6694/13/7/1743 2021-04-01 None